SFG
TARO

Steward Financial Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Steward Financial Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26
Closed – – 1065
2023
Q1 		$0 Buy
26
+21
+420% +$612 ﹤0.01% 952
2022
Q4 		$0 Buy
+5
New +$148 ﹤0.01% 871
2022
Q3 		– Sell
-5
Closed – – 1418
2022
Q2 		$0 Buy
+5
New +$191 ﹤0.01% 1460

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Steward Financial Group's TARO Position: Q2 2023 in Review

Steward Financial Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 26 shares.

Steward Financial Group first reported a position in TARO in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q1 2023. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

  • Steward Financial Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
  • Steward Financial Group sold 26 Taro Pharmaceutical Industries Ltd. shares in Q2 2023.
  • Steward Financial Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2022 and held it in 3 quarters.
  • Steward Financial Group's Taro Pharmaceutical Industries Ltd. position peaked at $0 in Q1 2023.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on Steward Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.